Take cognitive/ emotional assessments and therapies to scale

By SharpBrains | December 3, 2016

—– Look­ing for­ward to the vir­tu­al sum­mit next week…we can’t wait to explore and dis­cuss, on Tues­day, Decem­ber 6th — how to Take cognitive/ emo­tion­al assess­ments and ther­a­pies to scale. Three dig­i­tal health entrepreneurs–who have col­lec­tive­ly raised over $75 mil­lion in ven­ture cap­i­tal in the last 18 months– and an investor will dis­cuss their respec­tive visions…

Read More

Announcement: Nine new excellent Speakers @ 2016 SharpBrains Virtual Summit

By SharpBrains | October 20, 2016

We are delight­ed to announce nine new excel­lent Speak­ers at the upcom­ing 2016 Sharp­Brains Vir­tu­al Sum­mit: Rein­vent­ing Brain Health in the Dig­i­tal Age (Decem­ber 6–8, 2016): Dr. Corey McCann, CEO of Pear Ther­a­peu­tics Debra Gilmore, Exec­u­tive Direc­tor of The Arrow­smith Pro­gram Edward Kli­phuis, Invest­ment Direc­tor at Mer­ck Ven­tures Eri­ka Jack­son, VP of Train­ing and Oper­a­tions for Wellcoaches…

Read More

Akili raises an additional $11.9M; brings Amgen, Merck, Pfizer and Shire to the digital medicine table

By SharpBrains | July 21, 2016

—– Akili Adds Amgen Ven­tures and M Ven­tures* to Series B Financ­ing, Increas­ing Round to $42.4 Mil­lion (press release): “Akili Inter­ac­tive Labs, Inc. (“Akili”), a dig­i­tal med­i­cine com­pa­ny devel­op­ing nov­el, non-phar­­ma­­co­log­i­­cal ther­a­peu­tics and diag­nos­tics for cog­ni­tive dis­or­ders, today announced an $11.9 mil­lion expan­sion of its recent Series B financing. 

Read More